Outlook of therapeutic and diagnostic competency of nanobodies against SARS-CoV-2: A systematic review

PURPOSE: The newly emerged coronavirus (SARS-CoV-2) continues to infect humans, and no completely efficient treatment has yet been found. Antibody therapy is one way to control infection caused by COVID-19, but the use of classical antibodies has many disadvantages. Heavy chain antibodies (HCAbs) ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Aria, Hamid, Mahmoodi, Fatemeh, Ghaheh, Hooria Seyedhosseini, Faranak mavandadnejad, Zare, Hamed, Heiat, Mohammad, Bakherad, Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730734/
https://www.ncbi.nlm.nih.gov/pubmed/34995616
http://dx.doi.org/10.1016/j.ab.2022.114546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730734/
https://www.ncbi.nlm.nih.gov/pubmed/34995616
http://dx.doi.org/10.1016/j.ab.2022.114546

Ejemplares similares